HLA-DRB111and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis
Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed a...
Gespeichert in:
Veröffentlicht in: | Proceedings of the National Academy of Sciences - PNAS 2015-12, Vol.112 (52), p.15970-15975 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 15975 |
---|---|
container_issue | 52 |
container_start_page | 15970 |
container_title | Proceedings of the National Academy of Sciences - PNAS |
container_volume | 112 |
creator | Ombrello, Michael J. Remmers, Elaine F. Tachmazidou, Ioanna Grom, Alexei Foell, Dirk Haas, Johannes-Peter Martini, Alberto Gattorno, Marco Özen, Seza Prahalad, Sampath Zeft, Andrew S. Bohnsack, John F. Mellins, Elizabeth D. Ilowite, Norman T. Russo, Ricardo Len, Claudio Hilario, Maria Odete E. Oliveira, Sheila Yeung, Rae S.M. Rosenberg, Alan Wedderburn, Lucy R. Anton, Jordi Schwarz, Tobias Hinks, Anne Bilginer, Yelda Park, Jane Cobb, Joanna Satorius, Colleen L. Han, Buhm Baskin, Elizabeth Signa, Sara Duerr, Richard H. Achkar, J. P. Kamboh, M. Ilyas Kaufman, Kenneth M. Kottyan, Leah C. Pinto, Dalila Scherer, Stephen W. Alarcón-Riquelme, Marta E. Docampo, Elisa Estivill, Xavier Gül, Ahmet de Bakker, Paul I. W. Raychaudhuri, Soumya Langefeld, Carl D. Thompson, Susan Zeggini, Eleftheria Thomson, Wendy Kastner, Daniel L. Woo, Patricia |
description | Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed an association study of 982 children with sJIA and 8,010 healthy control subjects from nine countries. Using meta-analysis of directly observed and imputed SNP genotypes and imputed classic HLA types, we identified the MHC locus as a bona fide susceptibility locus with effects on sJIA risk that transcended geographically defined strata. The strongest sJIA-associated SNP, rs151043342 [P= 2.8 × 10−17, odds ratio (OR) 2.6 (2.1, 3.3)], was part of a cluster of 482 sJIA-associated SNPs that spanned a 400-kb region and included the class II HLA region. Conditional analysis controlling for the effect of rs151043342 found that rs12722051 independently influenced sJIA risk [P= 1.0 × 10−5, OR 0.7 (0.6, 0.8)]. Meta-analysis of imputed classic HLA-type associations in six study populations of Western European ancestry revealed thatHLA-DRB1*11and its defining amino acid residue, glutamate 58, were strongly associated with sJIA [P= 2.7 × 10−16, OR 2.3 (1.9, 2.8)], as was theHLA-DRB1*11—HLA-DQA1*05—HLA-DQB1*03haplotype [6.4 × 10−17, OR 2.3 (1.9, 2.9)]. By examining the MHC locus in the largest collection of sJIA patients assembled to date, this study solidifies the relationship between the class II HLA region and sJIA, implicating adaptive immune molecules in the pathogenesis of sJIA. |
format | Article |
fullrecord | <record><control><sourceid>jstor</sourceid><recordid>TN_cdi_jstor_primary_26466266</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>26466266</jstor_id><sourcerecordid>26466266</sourcerecordid><originalsourceid>FETCH-jstor_primary_264662663</originalsourceid><addsrcrecordid>eNqFjMuKwkAQAAdRMLp-wkL_QGAmZkdz3PVBBL0sew9NnJjOJpnQPQr-vR68eyqoghqpyOjMxDbN9FhFWiereJ0m6VTNRBqtdfa11pGS_Pgdb39_jDHYn-GGTNgHAV9BqB2c8g2ULYrA4QCtL68CyA4ksO8vwCT_UGEZPAtUnkHuElxHJTTXm-updUBn8gOG-umQQ80USD7UpMJW3OLFufrc7_42edzI81QMTB3yvUhsam1i7fJdfwAlHUeX</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>HLA-DRB111and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis</title><source>Jstor Complete Legacy</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Ombrello, Michael J. ; Remmers, Elaine F. ; Tachmazidou, Ioanna ; Grom, Alexei ; Foell, Dirk ; Haas, Johannes-Peter ; Martini, Alberto ; Gattorno, Marco ; Özen, Seza ; Prahalad, Sampath ; Zeft, Andrew S. ; Bohnsack, John F. ; Mellins, Elizabeth D. ; Ilowite, Norman T. ; Russo, Ricardo ; Len, Claudio ; Hilario, Maria Odete E. ; Oliveira, Sheila ; Yeung, Rae S.M. ; Rosenberg, Alan ; Wedderburn, Lucy R. ; Anton, Jordi ; Schwarz, Tobias ; Hinks, Anne ; Bilginer, Yelda ; Park, Jane ; Cobb, Joanna ; Satorius, Colleen L. ; Han, Buhm ; Baskin, Elizabeth ; Signa, Sara ; Duerr, Richard H. ; Achkar, J. P. ; Kamboh, M. Ilyas ; Kaufman, Kenneth M. ; Kottyan, Leah C. ; Pinto, Dalila ; Scherer, Stephen W. ; Alarcón-Riquelme, Marta E. ; Docampo, Elisa ; Estivill, Xavier ; Gül, Ahmet ; de Bakker, Paul I. W. ; Raychaudhuri, Soumya ; Langefeld, Carl D. ; Thompson, Susan ; Zeggini, Eleftheria ; Thomson, Wendy ; Kastner, Daniel L. ; Woo, Patricia</creator><creatorcontrib>Ombrello, Michael J. ; Remmers, Elaine F. ; Tachmazidou, Ioanna ; Grom, Alexei ; Foell, Dirk ; Haas, Johannes-Peter ; Martini, Alberto ; Gattorno, Marco ; Özen, Seza ; Prahalad, Sampath ; Zeft, Andrew S. ; Bohnsack, John F. ; Mellins, Elizabeth D. ; Ilowite, Norman T. ; Russo, Ricardo ; Len, Claudio ; Hilario, Maria Odete E. ; Oliveira, Sheila ; Yeung, Rae S.M. ; Rosenberg, Alan ; Wedderburn, Lucy R. ; Anton, Jordi ; Schwarz, Tobias ; Hinks, Anne ; Bilginer, Yelda ; Park, Jane ; Cobb, Joanna ; Satorius, Colleen L. ; Han, Buhm ; Baskin, Elizabeth ; Signa, Sara ; Duerr, Richard H. ; Achkar, J. P. ; Kamboh, M. Ilyas ; Kaufman, Kenneth M. ; Kottyan, Leah C. ; Pinto, Dalila ; Scherer, Stephen W. ; Alarcón-Riquelme, Marta E. ; Docampo, Elisa ; Estivill, Xavier ; Gül, Ahmet ; de Bakker, Paul I. W. ; Raychaudhuri, Soumya ; Langefeld, Carl D. ; Thompson, Susan ; Zeggini, Eleftheria ; Thomson, Wendy ; Kastner, Daniel L. ; Woo, Patricia ; British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group ; International Childhood Arthritis Genetics (INCHARGE) Consortium ; Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group ; Biologically Based Outcome Predictors in JIA (BBOP) Group ; Childhood Arthritis Prospective Study (CAPS) Group ; Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators</creatorcontrib><description>Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed an association study of 982 children with sJIA and 8,010 healthy control subjects from nine countries. Using meta-analysis of directly observed and imputed SNP genotypes and imputed classic HLA types, we identified the MHC locus as a bona fide susceptibility locus with effects on sJIA risk that transcended geographically defined strata. The strongest sJIA-associated SNP, rs151043342 [P= 2.8 × 10−17, odds ratio (OR) 2.6 (2.1, 3.3)], was part of a cluster of 482 sJIA-associated SNPs that spanned a 400-kb region and included the class II HLA region. Conditional analysis controlling for the effect of rs151043342 found that rs12722051 independently influenced sJIA risk [P= 1.0 × 10−5, OR 0.7 (0.6, 0.8)]. Meta-analysis of imputed classic HLA-type associations in six study populations of Western European ancestry revealed thatHLA-DRB1*11and its defining amino acid residue, glutamate 58, were strongly associated with sJIA [P= 2.7 × 10−16, OR 2.3 (1.9, 2.8)], as was theHLA-DRB1*11—HLA-DQA1*05—HLA-DQB1*03haplotype [6.4 × 10−17, OR 2.3 (1.9, 2.9)]. By examining the MHC locus in the largest collection of sJIA patients assembled to date, this study solidifies the relationship between the class II HLA region and sJIA, implicating adaptive immune molecules in the pathogenesis of sJIA.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><language>eng</language><publisher>National Academy of Sciences</publisher><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (52), p.15970-15975</ispartof><rights>Volumes 1–89 and 106–112, copyright as a collective work only; author(s) retains copyright to individual articles</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/26466266$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/26466266$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,57994,58227</link.rule.ids></links><search><creatorcontrib>Ombrello, Michael J.</creatorcontrib><creatorcontrib>Remmers, Elaine F.</creatorcontrib><creatorcontrib>Tachmazidou, Ioanna</creatorcontrib><creatorcontrib>Grom, Alexei</creatorcontrib><creatorcontrib>Foell, Dirk</creatorcontrib><creatorcontrib>Haas, Johannes-Peter</creatorcontrib><creatorcontrib>Martini, Alberto</creatorcontrib><creatorcontrib>Gattorno, Marco</creatorcontrib><creatorcontrib>Özen, Seza</creatorcontrib><creatorcontrib>Prahalad, Sampath</creatorcontrib><creatorcontrib>Zeft, Andrew S.</creatorcontrib><creatorcontrib>Bohnsack, John F.</creatorcontrib><creatorcontrib>Mellins, Elizabeth D.</creatorcontrib><creatorcontrib>Ilowite, Norman T.</creatorcontrib><creatorcontrib>Russo, Ricardo</creatorcontrib><creatorcontrib>Len, Claudio</creatorcontrib><creatorcontrib>Hilario, Maria Odete E.</creatorcontrib><creatorcontrib>Oliveira, Sheila</creatorcontrib><creatorcontrib>Yeung, Rae S.M.</creatorcontrib><creatorcontrib>Rosenberg, Alan</creatorcontrib><creatorcontrib>Wedderburn, Lucy R.</creatorcontrib><creatorcontrib>Anton, Jordi</creatorcontrib><creatorcontrib>Schwarz, Tobias</creatorcontrib><creatorcontrib>Hinks, Anne</creatorcontrib><creatorcontrib>Bilginer, Yelda</creatorcontrib><creatorcontrib>Park, Jane</creatorcontrib><creatorcontrib>Cobb, Joanna</creatorcontrib><creatorcontrib>Satorius, Colleen L.</creatorcontrib><creatorcontrib>Han, Buhm</creatorcontrib><creatorcontrib>Baskin, Elizabeth</creatorcontrib><creatorcontrib>Signa, Sara</creatorcontrib><creatorcontrib>Duerr, Richard H.</creatorcontrib><creatorcontrib>Achkar, J. P.</creatorcontrib><creatorcontrib>Kamboh, M. Ilyas</creatorcontrib><creatorcontrib>Kaufman, Kenneth M.</creatorcontrib><creatorcontrib>Kottyan, Leah C.</creatorcontrib><creatorcontrib>Pinto, Dalila</creatorcontrib><creatorcontrib>Scherer, Stephen W.</creatorcontrib><creatorcontrib>Alarcón-Riquelme, Marta E.</creatorcontrib><creatorcontrib>Docampo, Elisa</creatorcontrib><creatorcontrib>Estivill, Xavier</creatorcontrib><creatorcontrib>Gül, Ahmet</creatorcontrib><creatorcontrib>de Bakker, Paul I. W.</creatorcontrib><creatorcontrib>Raychaudhuri, Soumya</creatorcontrib><creatorcontrib>Langefeld, Carl D.</creatorcontrib><creatorcontrib>Thompson, Susan</creatorcontrib><creatorcontrib>Zeggini, Eleftheria</creatorcontrib><creatorcontrib>Thomson, Wendy</creatorcontrib><creatorcontrib>Kastner, Daniel L.</creatorcontrib><creatorcontrib>Woo, Patricia</creatorcontrib><creatorcontrib>British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group</creatorcontrib><creatorcontrib>International Childhood Arthritis Genetics (INCHARGE) Consortium</creatorcontrib><creatorcontrib>Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group</creatorcontrib><creatorcontrib>Biologically Based Outcome Predictors in JIA (BBOP) Group</creatorcontrib><creatorcontrib>Childhood Arthritis Prospective Study (CAPS) Group</creatorcontrib><creatorcontrib>Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators</creatorcontrib><title>HLA-DRB111and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis</title><title>Proceedings of the National Academy of Sciences - PNAS</title><description>Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed an association study of 982 children with sJIA and 8,010 healthy control subjects from nine countries. Using meta-analysis of directly observed and imputed SNP genotypes and imputed classic HLA types, we identified the MHC locus as a bona fide susceptibility locus with effects on sJIA risk that transcended geographically defined strata. The strongest sJIA-associated SNP, rs151043342 [P= 2.8 × 10−17, odds ratio (OR) 2.6 (2.1, 3.3)], was part of a cluster of 482 sJIA-associated SNPs that spanned a 400-kb region and included the class II HLA region. Conditional analysis controlling for the effect of rs151043342 found that rs12722051 independently influenced sJIA risk [P= 1.0 × 10−5, OR 0.7 (0.6, 0.8)]. Meta-analysis of imputed classic HLA-type associations in six study populations of Western European ancestry revealed thatHLA-DRB1*11and its defining amino acid residue, glutamate 58, were strongly associated with sJIA [P= 2.7 × 10−16, OR 2.3 (1.9, 2.8)], as was theHLA-DRB1*11—HLA-DQA1*05—HLA-DQB1*03haplotype [6.4 × 10−17, OR 2.3 (1.9, 2.9)]. By examining the MHC locus in the largest collection of sJIA patients assembled to date, this study solidifies the relationship between the class II HLA region and sJIA, implicating adaptive immune molecules in the pathogenesis of sJIA.</description><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqFjMuKwkAQAAdRMLp-wkL_QGAmZkdz3PVBBL0sew9NnJjOJpnQPQr-vR68eyqoghqpyOjMxDbN9FhFWiereJ0m6VTNRBqtdfa11pGS_Pgdb39_jDHYn-GGTNgHAV9BqB2c8g2ULYrA4QCtL68CyA4ksO8vwCT_UGEZPAtUnkHuElxHJTTXm-updUBn8gOG-umQQ80USD7UpMJW3OLFufrc7_42edzI81QMTB3yvUhsam1i7fJdfwAlHUeX</recordid><startdate>20151229</startdate><enddate>20151229</enddate><creator>Ombrello, Michael J.</creator><creator>Remmers, Elaine F.</creator><creator>Tachmazidou, Ioanna</creator><creator>Grom, Alexei</creator><creator>Foell, Dirk</creator><creator>Haas, Johannes-Peter</creator><creator>Martini, Alberto</creator><creator>Gattorno, Marco</creator><creator>Özen, Seza</creator><creator>Prahalad, Sampath</creator><creator>Zeft, Andrew S.</creator><creator>Bohnsack, John F.</creator><creator>Mellins, Elizabeth D.</creator><creator>Ilowite, Norman T.</creator><creator>Russo, Ricardo</creator><creator>Len, Claudio</creator><creator>Hilario, Maria Odete E.</creator><creator>Oliveira, Sheila</creator><creator>Yeung, Rae S.M.</creator><creator>Rosenberg, Alan</creator><creator>Wedderburn, Lucy R.</creator><creator>Anton, Jordi</creator><creator>Schwarz, Tobias</creator><creator>Hinks, Anne</creator><creator>Bilginer, Yelda</creator><creator>Park, Jane</creator><creator>Cobb, Joanna</creator><creator>Satorius, Colleen L.</creator><creator>Han, Buhm</creator><creator>Baskin, Elizabeth</creator><creator>Signa, Sara</creator><creator>Duerr, Richard H.</creator><creator>Achkar, J. P.</creator><creator>Kamboh, M. Ilyas</creator><creator>Kaufman, Kenneth M.</creator><creator>Kottyan, Leah C.</creator><creator>Pinto, Dalila</creator><creator>Scherer, Stephen W.</creator><creator>Alarcón-Riquelme, Marta E.</creator><creator>Docampo, Elisa</creator><creator>Estivill, Xavier</creator><creator>Gül, Ahmet</creator><creator>de Bakker, Paul I. W.</creator><creator>Raychaudhuri, Soumya</creator><creator>Langefeld, Carl D.</creator><creator>Thompson, Susan</creator><creator>Zeggini, Eleftheria</creator><creator>Thomson, Wendy</creator><creator>Kastner, Daniel L.</creator><creator>Woo, Patricia</creator><general>National Academy of Sciences</general><scope/></search><sort><creationdate>20151229</creationdate><title>HLA-DRB111and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis</title><author>Ombrello, Michael J. ; Remmers, Elaine F. ; Tachmazidou, Ioanna ; Grom, Alexei ; Foell, Dirk ; Haas, Johannes-Peter ; Martini, Alberto ; Gattorno, Marco ; Özen, Seza ; Prahalad, Sampath ; Zeft, Andrew S. ; Bohnsack, John F. ; Mellins, Elizabeth D. ; Ilowite, Norman T. ; Russo, Ricardo ; Len, Claudio ; Hilario, Maria Odete E. ; Oliveira, Sheila ; Yeung, Rae S.M. ; Rosenberg, Alan ; Wedderburn, Lucy R. ; Anton, Jordi ; Schwarz, Tobias ; Hinks, Anne ; Bilginer, Yelda ; Park, Jane ; Cobb, Joanna ; Satorius, Colleen L. ; Han, Buhm ; Baskin, Elizabeth ; Signa, Sara ; Duerr, Richard H. ; Achkar, J. P. ; Kamboh, M. Ilyas ; Kaufman, Kenneth M. ; Kottyan, Leah C. ; Pinto, Dalila ; Scherer, Stephen W. ; Alarcón-Riquelme, Marta E. ; Docampo, Elisa ; Estivill, Xavier ; Gül, Ahmet ; de Bakker, Paul I. W. ; Raychaudhuri, Soumya ; Langefeld, Carl D. ; Thompson, Susan ; Zeggini, Eleftheria ; Thomson, Wendy ; Kastner, Daniel L. ; Woo, Patricia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-jstor_primary_264662663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ombrello, Michael J.</creatorcontrib><creatorcontrib>Remmers, Elaine F.</creatorcontrib><creatorcontrib>Tachmazidou, Ioanna</creatorcontrib><creatorcontrib>Grom, Alexei</creatorcontrib><creatorcontrib>Foell, Dirk</creatorcontrib><creatorcontrib>Haas, Johannes-Peter</creatorcontrib><creatorcontrib>Martini, Alberto</creatorcontrib><creatorcontrib>Gattorno, Marco</creatorcontrib><creatorcontrib>Özen, Seza</creatorcontrib><creatorcontrib>Prahalad, Sampath</creatorcontrib><creatorcontrib>Zeft, Andrew S.</creatorcontrib><creatorcontrib>Bohnsack, John F.</creatorcontrib><creatorcontrib>Mellins, Elizabeth D.</creatorcontrib><creatorcontrib>Ilowite, Norman T.</creatorcontrib><creatorcontrib>Russo, Ricardo</creatorcontrib><creatorcontrib>Len, Claudio</creatorcontrib><creatorcontrib>Hilario, Maria Odete E.</creatorcontrib><creatorcontrib>Oliveira, Sheila</creatorcontrib><creatorcontrib>Yeung, Rae S.M.</creatorcontrib><creatorcontrib>Rosenberg, Alan</creatorcontrib><creatorcontrib>Wedderburn, Lucy R.</creatorcontrib><creatorcontrib>Anton, Jordi</creatorcontrib><creatorcontrib>Schwarz, Tobias</creatorcontrib><creatorcontrib>Hinks, Anne</creatorcontrib><creatorcontrib>Bilginer, Yelda</creatorcontrib><creatorcontrib>Park, Jane</creatorcontrib><creatorcontrib>Cobb, Joanna</creatorcontrib><creatorcontrib>Satorius, Colleen L.</creatorcontrib><creatorcontrib>Han, Buhm</creatorcontrib><creatorcontrib>Baskin, Elizabeth</creatorcontrib><creatorcontrib>Signa, Sara</creatorcontrib><creatorcontrib>Duerr, Richard H.</creatorcontrib><creatorcontrib>Achkar, J. P.</creatorcontrib><creatorcontrib>Kamboh, M. Ilyas</creatorcontrib><creatorcontrib>Kaufman, Kenneth M.</creatorcontrib><creatorcontrib>Kottyan, Leah C.</creatorcontrib><creatorcontrib>Pinto, Dalila</creatorcontrib><creatorcontrib>Scherer, Stephen W.</creatorcontrib><creatorcontrib>Alarcón-Riquelme, Marta E.</creatorcontrib><creatorcontrib>Docampo, Elisa</creatorcontrib><creatorcontrib>Estivill, Xavier</creatorcontrib><creatorcontrib>Gül, Ahmet</creatorcontrib><creatorcontrib>de Bakker, Paul I. W.</creatorcontrib><creatorcontrib>Raychaudhuri, Soumya</creatorcontrib><creatorcontrib>Langefeld, Carl D.</creatorcontrib><creatorcontrib>Thompson, Susan</creatorcontrib><creatorcontrib>Zeggini, Eleftheria</creatorcontrib><creatorcontrib>Thomson, Wendy</creatorcontrib><creatorcontrib>Kastner, Daniel L.</creatorcontrib><creatorcontrib>Woo, Patricia</creatorcontrib><creatorcontrib>British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group</creatorcontrib><creatorcontrib>International Childhood Arthritis Genetics (INCHARGE) Consortium</creatorcontrib><creatorcontrib>Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group</creatorcontrib><creatorcontrib>Biologically Based Outcome Predictors in JIA (BBOP) Group</creatorcontrib><creatorcontrib>Childhood Arthritis Prospective Study (CAPS) Group</creatorcontrib><creatorcontrib>Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators</creatorcontrib><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ombrello, Michael J.</au><au>Remmers, Elaine F.</au><au>Tachmazidou, Ioanna</au><au>Grom, Alexei</au><au>Foell, Dirk</au><au>Haas, Johannes-Peter</au><au>Martini, Alberto</au><au>Gattorno, Marco</au><au>Özen, Seza</au><au>Prahalad, Sampath</au><au>Zeft, Andrew S.</au><au>Bohnsack, John F.</au><au>Mellins, Elizabeth D.</au><au>Ilowite, Norman T.</au><au>Russo, Ricardo</au><au>Len, Claudio</au><au>Hilario, Maria Odete E.</au><au>Oliveira, Sheila</au><au>Yeung, Rae S.M.</au><au>Rosenberg, Alan</au><au>Wedderburn, Lucy R.</au><au>Anton, Jordi</au><au>Schwarz, Tobias</au><au>Hinks, Anne</au><au>Bilginer, Yelda</au><au>Park, Jane</au><au>Cobb, Joanna</au><au>Satorius, Colleen L.</au><au>Han, Buhm</au><au>Baskin, Elizabeth</au><au>Signa, Sara</au><au>Duerr, Richard H.</au><au>Achkar, J. P.</au><au>Kamboh, M. Ilyas</au><au>Kaufman, Kenneth M.</au><au>Kottyan, Leah C.</au><au>Pinto, Dalila</au><au>Scherer, Stephen W.</au><au>Alarcón-Riquelme, Marta E.</au><au>Docampo, Elisa</au><au>Estivill, Xavier</au><au>Gül, Ahmet</au><au>de Bakker, Paul I. W.</au><au>Raychaudhuri, Soumya</au><au>Langefeld, Carl D.</au><au>Thompson, Susan</au><au>Zeggini, Eleftheria</au><au>Thomson, Wendy</au><au>Kastner, Daniel L.</au><au>Woo, Patricia</au><aucorp>British Society of Pediatric and Adolescent Rheumatology (BSPAR) Study Group</aucorp><aucorp>International Childhood Arthritis Genetics (INCHARGE) Consortium</aucorp><aucorp>Sparks-Childhood Arthritis Response to Medication Study (CHARMS) Group</aucorp><aucorp>Biologically Based Outcome Predictors in JIA (BBOP) Group</aucorp><aucorp>Childhood Arthritis Prospective Study (CAPS) Group</aucorp><aucorp>Randomized Placebo Phase Study of Rilonacept in sJIA (RAPPORT) Investigators</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>HLA-DRB111and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><date>2015-12-29</date><risdate>2015</risdate><volume>112</volume><issue>52</issue><spage>15970</spage><epage>15975</epage><pages>15970-15975</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>Systemic juvenile idiopathic arthritis (sJIA) is an often severe, potentially life-threatening childhood inflammatory disease, the pathophysiology of which is poorly understood. To determine whether genetic variation within the MHC locus on chromosome 6 influences sJIA susceptibility, we performed an association study of 982 children with sJIA and 8,010 healthy control subjects from nine countries. Using meta-analysis of directly observed and imputed SNP genotypes and imputed classic HLA types, we identified the MHC locus as a bona fide susceptibility locus with effects on sJIA risk that transcended geographically defined strata. The strongest sJIA-associated SNP, rs151043342 [P= 2.8 × 10−17, odds ratio (OR) 2.6 (2.1, 3.3)], was part of a cluster of 482 sJIA-associated SNPs that spanned a 400-kb region and included the class II HLA region. Conditional analysis controlling for the effect of rs151043342 found that rs12722051 independently influenced sJIA risk [P= 1.0 × 10−5, OR 0.7 (0.6, 0.8)]. Meta-analysis of imputed classic HLA-type associations in six study populations of Western European ancestry revealed thatHLA-DRB1*11and its defining amino acid residue, glutamate 58, were strongly associated with sJIA [P= 2.7 × 10−16, OR 2.3 (1.9, 2.8)], as was theHLA-DRB1*11—HLA-DQA1*05—HLA-DQB1*03haplotype [6.4 × 10−17, OR 2.3 (1.9, 2.9)]. By examining the MHC locus in the largest collection of sJIA patients assembled to date, this study solidifies the relationship between the class II HLA region and sJIA, implicating adaptive immune molecules in the pathogenesis of sJIA.</abstract><pub>National Academy of Sciences</pub></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0027-8424 |
ispartof | Proceedings of the National Academy of Sciences - PNAS, 2015-12, Vol.112 (52), p.15970-15975 |
issn | 0027-8424 1091-6490 |
language | eng |
recordid | cdi_jstor_primary_26466266 |
source | Jstor Complete Legacy; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry |
title | HLA-DRB111and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T09%3A35%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=HLA-DRB111and%20variants%20of%20the%20MHC%20class%20II%20locus%20are%20strong%20risk%20factors%20for%20systemic%20juvenile%20idiopathic%20arthritis&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Ombrello,%20Michael%20J.&rft.aucorp=British%20Society%20of%20Pediatric%20and%20Adolescent%20Rheumatology%20(BSPAR)%20Study%20Group&rft.date=2015-12-29&rft.volume=112&rft.issue=52&rft.spage=15970&rft.epage=15975&rft.pages=15970-15975&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/&rft_dat=%3Cjstor%3E26466266%3C/jstor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_jstor_id=26466266&rfr_iscdi=true |